about
Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson diseaseDynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementiaEvidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane.Defective autophagy in Parkinson's disease: role of oxidative stress.Molecular biomarkers of neurodegeneration.Cognitive decline in Parkinson disease.Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA)Impaired synaptic function is linked to cognition in Parkinson's disease.Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons.Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits α-synuclein aggregation in hippocampus and striatum in aged mice.The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease.
P2860
Q34299923-AC191454-4477-4EE9-864B-527072B1F642Q35022169-2FB31601-5CA2-47F2-ACFE-0566F6CE973BQ35667600-02EDF711-B6DF-451A-BEB9-B16723DBFBC8Q36100136-13649E71-6499-4CF4-A87F-7D2ACE733348Q38035191-16987B5E-5710-4E9A-B631-FB168005D104Q38154930-B203A4EF-CD1C-4615-BF80-914A1D50F939Q38751099-D0408968-DE8A-4168-B66B-58C423B25F0BQ39006845-3A5DC629-1916-4666-9819-B5EE254A5F37Q42373778-D83307C6-FE8D-42A0-8539-09167C4DE731Q47786283-B803003C-635E-4BE6-B88F-5221E94EDB84Q47869899-9D711E6E-76CA-4A8B-9113-7BEAABF308DEQ48091456-C9BE1F82-95D6-4AC0-8DC7-94683DDBCC97Q48598969-80EA6569-737C-4CE6-8CB5-F6CFF3916DE0Q50558906-FAB72AF0-6F0A-409E-9E90-D30852E36F47Q53478796-95E64D6B-1A34-4421-B723-C75D7B12B519
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Synaptic protein alterations in Parkinson's disease.
@en
Synaptic protein alterations in Parkinson's disease.
@nl
type
label
Synaptic protein alterations in Parkinson's disease.
@en
Synaptic protein alterations in Parkinson's disease.
@nl
prefLabel
Synaptic protein alterations in Parkinson's disease.
@en
Synaptic protein alterations in Parkinson's disease.
@nl
P2860
P1476
Synaptic protein alterations in Parkinson's disease
@en
P2093
David Dexter
Ilse S Pienaar
P2860
P2888
P304
P356
10.1007/S12035-011-8226-9
P577
2011-12-29T00:00:00Z